Company page

Biofrontera Ag

Biofrontera AG is a public company listed under the ticker B8FK in the German market. The company has a market capitalization of approximately €16.36 million. Biofrontera focuses on developing and commercializing dermatological products, particularly for skin cancer and other skin conditions.

profileB8FK:XETRAI content: aiUpdated June 24, 2026/company/biofrontera-ag/c-rc2cfr6p
Biofrontera Ag logo
Ticker
B8FK:XETR
Asset type
Stock
Market cap
$16.4M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
XETR
Currency
EUR